Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional

Study of Talabostat and Pemetrexed vs. Pemetrexed in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy

ClinicalTrials.gov ID: NCT00290017

Public ClinicalTrials.gov record NCT00290017. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 26, 2026, 1:36 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-Blind, Multicenter Study of Talabostat and Pemetrexed vs. Pemetrexed and Placebo in Patients With Advanced (Stage IIIB/IV) Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This Phase 3 study will compare the efficacy of talabostat plus pemetrexed to pemetrexed plus placebo in patients with Stage IIIB/IV NSCLC who have failed a platinum-based chemotherapy regimen.

Study identification

NCT ID
NCT00290017
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Point Therapeutics
Industry
Enrollment
400 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2006
Primary completion
Not listed
Completion
Not listed
Last update posted
Jun 7, 2007

Started 2006

United States locations

U.S. sites
101
U.S. states
31
U.S. cities
87
Facility City State ZIP Site status
Marshall Schreeder, MD Huntsville Alabama 35801 —
Hematology Oncology Associates Phoenix Arizona 85012 —
Heritage Physician Group-Oncology Hot Springs Arkansas 71913 —
Raul R. Mena, MD Burbank California 91505-4866 —
Pacific Coast Hematology / Oncology Medical Group, Inc. Fountain Valley California 92708 —
Robert A. Moss, MD, FACP, Inc. Fountain Valley California 92708 —
Antelope Valley Cancer Center Lancaster California 93534 —
Warren Paroly, MD Oceanside California 92056 —
Southwest Cancer Care Medical Group Poway California 92064 —
Mile High Oncology Denver Colorado 80210 —
Medical Specialists of Fairfield Fairfield Connecticut 06824 —
Northwestern Connecticut Oncology Hematology Associates, LLP Torrington Connecticut 06790 —
Lucio Gordan, MD Gainesville Florida 32605 —
Cancer and Blood Disease Center Lecanto Florida 34461 —
Ocala Oncology Center Ocala Florida 34474 —
Cancer Center of Florida Ocoee Florida 34761 —
Northeast Georgia Cancer Care, LLC Athens Georgia 30607 —
North Idaho Cancer Center Coeur d'Alene Idaho 83814 —
Hematology Oncology Associates of Illinois Chicago Illinois 60611 —
Joliet Oncology-Hematology Associates Joliet Illinois 60435 —
American Health Network of Indiana--Hematology/Oncology Indianapolis Indiana 46202 —
Arnett Cancer Center Lafayette Indiana 08822 —
Northern Indiana Oncology Associates South Bend Indiana 46617 —
Associated Physicians and Surgeons, LLC Terre Haute Indiana 47804-4080 —
HUX Cancer Center/Union Hospital Terre Haute Indiana 47804-4080 —
Kansas City Cancer Center, LLC Overland Park Kansas 66210 —
Kentucky Cancer Clinic Hazard Kentucky 41701 —
Mercy Medical Center Baltimore Maryland 21202 —
Chesapeake Oncology Hematology Associates (Tate Center) Glen Burnie Maryland 21061 —
Carroll County Cancer Center Westminster Maryland 21157 —
Fallon Clinic, Inc. at Worcester Medical Center Worcester Massachusetts 01608 —
Michael McKenzie, DO Clinton Township Michigan 48038 —
Youssef Hanna, MD Port Huron Michigan 48060 —
Cancer and Transplant Consultants, PLC Rochester Hills Michigan 48307 —
Cancer Care Associates Rochester Hills Michigan 48307 —
Cancer Care Associates, PC Royal Oak Michigan 48073 —
Hematology Oncology Consultants Royal Oak Michigan 48073 —
Jeffrey H. Margolis, MD Royal Oak Michigan 48073 —
William Beaumont Hospital Royal Oak Michigan 48073 —
Dr. Folbe, MD/PC Troy Michigan 48085 —
William Beaumont Hospital Troy Michigan 48085 —
Minnesota Oncology Hematology, PA Burnsville Minnesota 55337 —
Minnesota Oncology Hematology, PA Minneapolis Minnesota 55404 —
St. Joseph Oncology, Inc. Saint Joseph Missouri 64507 —
Comprehensive Cancer Centers of Nevada Las Vegas Nevada 89109 —
VA Sierra Nevada Health Care System Reno Nevada 89502 —
Hunterdon Regional Cancer Center Flemington New Jersey 08822 —
Monmouth Medical Center Long Branch New Jersey 07740 —
Hematology Oncology Associates, SJ, PA Mount Holly New Jersey 08060 —
Capital Health System Trenton New Jersey 08618 —
Mercer Bucks Oncology/Hematology Trenton New Jersey 08618 —
New York Oncology Hematology, PC Albany New York 12208 —
Northwestern Carolina Oncology & Hematology, PA Hickory North Carolina 28602 —
Eugene Paschold, MD Winston-Salem North Carolina 27013 —
Piedmont Hematology Oncology / Winston-Salem Winston-Salem North Carolina 27103 —
Oncology/Hematology Care, Inc. Cincinnati Ohio 45242 —
Dayton Oncology & Hematology, PA Kettering Ohio 45409 —
Cancer Care Associates Oklahoma City Oklahoma 73120 —
Cancer Care Associates Tulsa Oklahoma 74136 —
Satish A. Shah, MD Gettysburg Pennsylvania 17325 —
Medical Oncology Associates of Wyoming Valley, PC Kingston Pennsylvania 18704 —
Hematology-Oncology Group, PC Langhorne Pennsylvania 19047 —
St. Mary Medical Center--Research Center Langhorne Pennsylvania 19047 —
Paoli Hospital Paoli Pennsylvania 19301 —
Rittenhouse Hematology Oncology Associates Philadelphia Pennsylvania 19146 —
Pottstown Memorial Medical Center Pottstown Pennsylvania 19464 —
Bux-Mont Oncology-Hematology Sellersville Pennsylvania 18960 —
Grandview Hospital Sellersville Pennsylvania — —
Cancer Care Institute of Carolina Aiken South Carolina 29801 —
Charleston Hematology Oncology, PA Charleston South Carolina 29403 —
Palmetto Hematology Oncology PC Spartanburg South Carolina 29303-3041 —
Associates in Oncology and Hematology Chattanooga Tennessee 37404 —
McLeod Cancer and Blood Center Johnson City Tennessee 37604 —
University of Tennessee Knoxville Tennessee 37920 —
Texas Cancer Center Arlington Texas 76014 —
Texas Oncology Cancer Center Austin Texas 78731 —
Texas Cancer Center (Dallas Southwest) Dallas Texas 75237 —
Mary Crowley Medical Research Center Dallas Texas 75246 —
Texas Cancer Center / Denton Denton Texas 76210 —
El Paso Cancer Treatment Center--East El Paso Texas 79915 —
Texas Oncology, PA El Paso Texas 79915 —
Texas Oncology, PA Fort Worth Texas 76104 —
US Oncology Research and Clinical Pharmacy Fort Worth Texas 76177 —
Joe Arrington Cancer Research and Treatment Center Lubbock Texas 79410 —
Texas Oncology, PA Mesquite Texas 75150 —
Texas Oncology, PA / Allison Cancer Center Midland Texas 79701-5946 —
West Texas Cancer Center Odessa Texas 79761 —
Paris Regional Cancer Center Paris Texas 75460-5004 —
Texas Oncology Cancer Center--Sugar Land Sugar Land Texas 77479 —
Tyler Cancer Center Tyler Texas 75702 —
Cancer Outreach Associates, PC / Outreach Clinical Trial Consortium LLC Abingdon Virginia 24211 —
Fairfax Northern Virginia Hematology / Oncology, PC Fairfax Virginia 22031 —
Virginia Oncology Associates Norfolk Virginia 23502 —
Virginia Physicians, Inc. Richmond Virginia 23229 —
Oncology & Hematology Associates of Southwest Virginia Salem Virginia 24153 —
Luke Walker, MD Everett Washington 98206 —
Cascade Cancer Center Kirkland Washington 98034-3013 —
Puget Sound Cancer Centers Seattle Washington 98133 —
Cancer Care Northwest Spokane Washington 99218 —
Northwest Cancer Specialists, PC Vancouver Washington 98684 —
Medical Consultants, Ltd. Milwaukee Wisconsin 53215 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00290017, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 7, 2007 · Synced Sep 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00290017 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →